These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 24291636)
1. Melatonin and its atheroprotective effects: a review. Favero G; Rodella LF; Reiter RJ; Rezzani R Mol Cell Endocrinol; 2014 Feb; 382(2):926-37. PubMed ID: 24291636 [TBL] [Abstract][Full Text] [Related]
2. Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin. Rezzani R; Favero G; Stacchiotti A; Rodella LF Life Sci; 2013 May; 92(17-19):875-82. PubMed ID: 23201430 [TBL] [Abstract][Full Text] [Related]
3. [Melatonin in the treatment of atherosclerosis]. Broncel M; Koziróg-Kołacińska M; Chojnowska-Jezierska J Pol Merkur Lekarski; 2007 Aug; 23(134):124-7. PubMed ID: 18044343 [TBL] [Abstract][Full Text] [Related]
4. Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state. Korkmaz A; Ma S; Topal T; Rosales-Corral S; Tan DX; Reiter RJ Mol Cell Endocrinol; 2012 Feb; 349(2):128-37. PubMed ID: 22079284 [TBL] [Abstract][Full Text] [Related]
5. Melatonin: a pleiotropic molecule regulating inflammation. Radogna F; Diederich M; Ghibelli L Biochem Pharmacol; 2010 Dec; 80(12):1844-52. PubMed ID: 20696138 [TBL] [Abstract][Full Text] [Related]
7. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709 [TBL] [Abstract][Full Text] [Related]
9. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769 [TBL] [Abstract][Full Text] [Related]
10. Melatonin: action as antioxidant and potential applications in human disease and aging. Bonnefont-Rousselot D; Collin F Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677 [TBL] [Abstract][Full Text] [Related]
11. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Hu S; Yin S; Jiang X; Huang D; Shen G Eur J Pharmacol; 2009 Aug; 616(1-3):287-92. PubMed ID: 19576882 [TBL] [Abstract][Full Text] [Related]
12. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. Manchester LC; Coto-Montes A; Boga JA; Andersen LP; Zhou Z; Galano A; Vriend J; Tan DX; Reiter RJ J Pineal Res; 2015 Nov; 59(4):403-19. PubMed ID: 26272235 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173 [TBL] [Abstract][Full Text] [Related]
14. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Leonarduzzi G; Gamba P; Gargiulo S; Biasi F; Poli G Free Radic Biol Med; 2012 Jan; 52(1):19-34. PubMed ID: 22037514 [TBL] [Abstract][Full Text] [Related]
16. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. Choi SI; Dadakhujaev S; Ryu H; Im Kim T; Kim EK J Pineal Res; 2011 Aug; 51(1):94-103. PubMed ID: 21392093 [TBL] [Abstract][Full Text] [Related]